Aimmune Therapeutics Q3 EPS $(1.03) Down From $(0.89) YoY

Aimmune Therapeutics (NASDAQ:AIMT) reported quarterly losses of $(1.03) per share. This is a 15.73 percent decrease over losses of $(0.89) per share from the same period last year.

Benzinga · 11/06/2019 21:33

Aimmune Therapeutics (NASDAQ:AIMT) reported quarterly losses of $(1.03) per share. This is a 15.73 percent decrease over losses of $(0.89) per share from the same period last year.